Theramyt Novobiologics Private
Theramyt is a unique bio-enterprise building tomorrow’s biologics – biobetters. We apply our drug designing and platform technology strengths to deliver novel therapies for disease areas such as oncology, rheumatoid arthritis, diabetes and metabolic disorders.
Investors
Technology:
Biologics
Funding Status:
Early Stage Venture
Investor Type:
For Profit
Investors Number:
5
Employee Number:
11-50
Last Funding Date:
2013-10-11
Headquarters:
Bengaluru, Karnataka, India
Last Funding Type:
Seed
Total Funding:
$1.5M
Founded Date:
2013
Industry:
PharmTech
Estimated Revenue:
$1M to $10M